Mighty mighty prostones: How Peter Greenleaf is reshaping Sucampo
August 06, 2014 at 17:32 PM EDT
Four months into his tenure as CEO of Sucampo Pharmaceuticals Inc., former MedImmune president Peter Greenleaf emerged this week with a new blueprint for the Bethesda drug-maker...
